Healthcare delivery for HIV-positive people with tuberculosis in Europe

Background In a 2013 survey, we reported distinct discrepancies in delivery of tuberculosis (TB) and HIV services in eastern Europe (EE) vs. western Europe (WE). Objectives To verify the differences in TB and HIV services in EE vs. WE. Methods Twenty-three sites completed a survey in 2018 (EE, 14; W...

Descripción completa

Detalles Bibliográficos
Autores: Bentzon, AK, Panteleev, A, Mitsura, V, Borodulina, E, Skrahina, A, Denisova, E, Tetradov, S, Podlasin, R, Riekstina, V, Kancauskiene, Z, Paduto, D, Mocroft, A, Trofimova, T, Miller, R, Post, F, Grezesczuk, A, Lundgren, JD, Inglot, M, Podlekareva, D, Bolokadze, N, Kirk, O, Millet J.P., Orcau A., TB HIV Study Grp
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p8167
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8167
http://hdl.handle.net/2445/185963
Access Level:acceso abierto
Palabra clave:clinical management
coinfection
eastern Europe
HIV
tuberculosis
western Europe
id ES_5fe99e1a83ed6486bfbdac1ea971a4e5
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p8167
network_acronym_str ES
network_name_str España
repository_id_str
spelling Healthcare delivery for HIV-positive people with tuberculosis in EuropeBentzon, AKPanteleev, AMitsura, VBorodulina, ESkrahina, ADenisova, ETetradov, SPodlasin, RRiekstina, VKancauskiene, ZPaduto, DMocroft, ATrofimova, TMiller, RPost, FGrezesczuk, ALundgren, JDInglot, MPodlekareva, DBolokadze, NKirk, OMillet J.P.Orcau A.TB HIV Study Grpclinical managementcoinfectioneastern EuropeHIVtuberculosiswestern EuropeBackground In a 2013 survey, we reported distinct discrepancies in delivery of tuberculosis (TB) and HIV services in eastern Europe (EE) vs. western Europe (WE). Objectives To verify the differences in TB and HIV services in EE vs. WE. Methods Twenty-three sites completed a survey in 2018 (EE, 14; WE, nine; 88% response rate). Results were compared across as well as within the two regions. When possible, results were compared with the 2013 survey. Results Delivery of healthcare was significantly less integrated in EE: provision of TB and HIV services at one site (36% in EE vs. 89% in WE; P = 0.034), and continued TB follow-up in one location (42% vs. 100%; P = 0.007). Although access to TB diagnostics, standard TB and HIV drugs was generally good, fewer sites in EE reported unlimited access to rifabutin/multi-drug-resistant TB (MDR-TB) drugs, HIV integrase inhibitors and opioid substitution therapy (OST). Compared with 2013, routine usage of GeneXpert was more common in EE in 2018 (54% vs. 92%; P = 0.073), as was access to moxifloxacin (46% vs. 91%; P = 0.033), linezolid (31% vs. 64%; P = 0.217), and bedaquiline (0% vs. 25%; P = 0.217). Integration of TB and HIV services (46% vs. 39%; P = 1.000) and provision of OST to patients with opioid dependency (54% vs. 46%; P = 0.695) remained unchanged. Conclusion Delivery of TB and HIV healthcare, including integration of TB and HIV care and access to MDR-TB drugs, still differs between WE and EE, as well as between individual EE sites.WILEY2021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8167http://hdl.handle.net/2445/185963HIV MEDICINEISSN: 14642662ISSNe: 14681293reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Inglésinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p81672026-06-14T12:41:47Z
dc.title.none.fl_str_mv Healthcare delivery for HIV-positive people with tuberculosis in Europe
title Healthcare delivery for HIV-positive people with tuberculosis in Europe
spellingShingle Healthcare delivery for HIV-positive people with tuberculosis in Europe
Bentzon, AK
clinical management
coinfection
eastern Europe
HIV
tuberculosis
western Europe
title_short Healthcare delivery for HIV-positive people with tuberculosis in Europe
title_full Healthcare delivery for HIV-positive people with tuberculosis in Europe
title_fullStr Healthcare delivery for HIV-positive people with tuberculosis in Europe
title_full_unstemmed Healthcare delivery for HIV-positive people with tuberculosis in Europe
title_sort Healthcare delivery for HIV-positive people with tuberculosis in Europe
dc.creator.none.fl_str_mv Bentzon, AK
Panteleev, A
Mitsura, V
Borodulina, E
Skrahina, A
Denisova, E
Tetradov, S
Podlasin, R
Riekstina, V
Kancauskiene, Z
Paduto, D
Mocroft, A
Trofimova, T
Miller, R
Post, F
Grezesczuk, A
Lundgren, JD
Inglot, M
Podlekareva, D
Bolokadze, N
Kirk, O
Millet J.P.
Orcau A.
TB HIV Study Grp
author Bentzon, AK
author_facet Bentzon, AK
Panteleev, A
Mitsura, V
Borodulina, E
Skrahina, A
Denisova, E
Tetradov, S
Podlasin, R
Riekstina, V
Kancauskiene, Z
Paduto, D
Mocroft, A
Trofimova, T
Miller, R
Post, F
Grezesczuk, A
Lundgren, JD
Inglot, M
Podlekareva, D
Bolokadze, N
Kirk, O
Millet J.P.
Orcau A.
TB HIV Study Grp
author_role author
author2 Panteleev, A
Mitsura, V
Borodulina, E
Skrahina, A
Denisova, E
Tetradov, S
Podlasin, R
Riekstina, V
Kancauskiene, Z
Paduto, D
Mocroft, A
Trofimova, T
Miller, R
Post, F
Grezesczuk, A
Lundgren, JD
Inglot, M
Podlekareva, D
Bolokadze, N
Kirk, O
Millet J.P.
Orcau A.
TB HIV Study Grp
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv clinical management
coinfection
eastern Europe
HIV
tuberculosis
western Europe
topic clinical management
coinfection
eastern Europe
HIV
tuberculosis
western Europe
description Background In a 2013 survey, we reported distinct discrepancies in delivery of tuberculosis (TB) and HIV services in eastern Europe (EE) vs. western Europe (WE). Objectives To verify the differences in TB and HIV services in EE vs. WE. Methods Twenty-three sites completed a survey in 2018 (EE, 14; WE, nine; 88% response rate). Results were compared across as well as within the two regions. When possible, results were compared with the 2013 survey. Results Delivery of healthcare was significantly less integrated in EE: provision of TB and HIV services at one site (36% in EE vs. 89% in WE; P = 0.034), and continued TB follow-up in one location (42% vs. 100%; P = 0.007). Although access to TB diagnostics, standard TB and HIV drugs was generally good, fewer sites in EE reported unlimited access to rifabutin/multi-drug-resistant TB (MDR-TB) drugs, HIV integrase inhibitors and opioid substitution therapy (OST). Compared with 2013, routine usage of GeneXpert was more common in EE in 2018 (54% vs. 92%; P = 0.073), as was access to moxifloxacin (46% vs. 91%; P = 0.033), linezolid (31% vs. 64%; P = 0.217), and bedaquiline (0% vs. 25%; P = 0.217). Integration of TB and HIV services (46% vs. 39%; P = 1.000) and provision of OST to patients with opioid dependency (54% vs. 46%; P = 0.695) remained unchanged. Conclusion Delivery of TB and HIV healthcare, including integration of TB and HIV care and access to MDR-TB drugs, still differs between WE and EE, as well as between individual EE sites.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8167
http://hdl.handle.net/2445/185963
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8167
http://hdl.handle.net/2445/185963
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv WILEY
publisher.none.fl_str_mv WILEY
dc.source.none.fl_str_mv HIV MEDICINE
ISSN: 14642662
ISSNe: 14681293
reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869409253413879808
score 15,812429

Similares en LA Referencia